当前位置:首页 - 行情中心 - 康众医疗(688607) - 财务分析 - 现金流量表

康众医疗

(688607)

  

流通市值:25.89亿  总市值:25.89亿
流通股本:8812.90万   总股本:8812.90万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金148,230,647.8269,670,228.34297,606,501.06219,284,143.39
  收到的税费返还5,545,942.831,936,494.3610,279,829.837,681,766.52
  收到其他与经营活动有关的现金6,576,173.451,047,415.639,767,038.3413,442,557.9
  经营活动现金流入小计160,352,764.172,654,138.33317,653,369.23240,408,467.81
  购买商品、接受劳务支付的现金131,496,317.1961,719,676.18167,825,717.37104,311,143.46
  支付给职工以及为职工支付的现金44,757,651.8324,234,018.7780,708,000.9856,638,771.87
  支付的各项税费5,218,509.535,888,325.349,712,154.447,783,497.28
  支付其他与经营活动有关的现金28,235,390.715,446,750.636,787,796.4446,560,815.19
  经营活动现金流出小计209,707,869.25107,288,770.89295,033,669.23215,294,227.8
  经营活动产生的现金流量净额-49,355,105.15-34,634,632.5622,619,70025,114,240.01
二、投资活动产生的现金流量:
  取得投资收益收到的现金2,851,736.11148,209.711,226,750.287,939,949.82
  处置固定资产、无形资产和其他长期资产收回的现金净额133,657.17-33,588.2-
  收到的其他与投资活动有关的现金1,048,510,000517,515,6001,684,502,1501,822,677,100
  投资活动现金流入小计1,051,495,393.28517,663,809.71,695,762,488.481,830,617,049.82
  购建固定资产、无形资产和其他长期资产支付的现金25,706,424.919,434,577.8696,204,755.4670,038,739.93
  投资支付的现金20,000,000-119,080,455.66107,500,465.52
  支付其他与投资活动有关的现金991,419,600494,554,8001,497,878,9501,633,811,700
  投资活动现金流出小计1,037,126,024.91503,989,377.861,713,164,161.121,811,350,905.45
  投资活动产生的现金流量净额14,369,368.3713,674,431.84-17,401,672.6419,266,144.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金309,725.99303,718.052,311,972.5-
  取得借款收到的现金20,000,000-5,311,566.455,301,966.45
  筹资活动现金流入小计20,309,725.99303,718.057,623,538.955,301,966.45
  偿还债务支付的现金2,585,236.862,585,236.8610,843,547.138,117,217.54
  分配股利、利润或偿付利息支付的现金5,370,197.09-5,018,959.545,115,237.14
  支付其他与筹资活动有关的现金966,786.8-15,444,143.4911,487,185.54
  筹资活动现金流出小计8,922,220.752,585,236.8631,306,650.1624,719,640.22
  筹资活动产生的现金流量净额11,387,505.24-2,281,518.81-23,683,111.21-19,417,673.77
四、汇率变动对现金及现金等价物的影响893,930.63472,456.55-1,801,903.66-3,682,869.02
五、现金及现金等价物净增加额-22,704,300.91-22,769,262.98-20,266,987.5121,279,841.59
  加:期初现金及现金等价物余额221,907,862.48221,907,862.48242,174,849.99242,174,849.99
  期末现金及现金等价物余额199,203,561.57199,138,599.5221,907,862.48263,454,691.58
补充资料:
  净利润-678,824.81-17,675,708.03-
  资产减值准备-85,757.17-5,329,912.79-
  固定资产和投资性房地产折旧1,406,680.69-2,500,439.45-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,406,680.69-2,500,439.45-
  无形资产摊销167,221.6-400,883.18-
  长期待摊费用摊销1,594,478.96-2,882,168.11-
  处置固定资产、无形资产和其他长期资产的损失-5,515.14-3,175.66-
  固定资产报废损失121,271.72---
  公允价值变动损失313,217-1,146,507.39-
  财务费用215,346.93-2,207,492.65-
  投资损失-821,072.79--6,535,540.82-
  递延所得税-2,194,235.79--453,018.79-
  其中:递延所得税资产减少-1,916,512.58--334,907.03-
    递延所得税负债增加-277,723.21--118,111.76-
  存货的减少-41,712,051.17-5,011,978-
  经营性应收项目的减少-19,424,654.12--29,339,454.18-
  经营性应付项目的增加433,551.83-14,957,687.67-
  其他420,035.85-556,320-
  现金的期末余额199,203,561.57-221,907,862.48-
  减:现金的期初余额221,907,862.48-242,174,849.99-
  现金及现金等价物的净增加额-22,704,300.91--20,266,987.51-
公告日期2025-08-232025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑